Study finds pinworm drug shows promise against rare skin cancer

A study from the University of Arizona Cancer Center found that pyrvinium pamoate, a common pinworm drug, may fight Merkel cell carcinoma—a rare, aggressive skin cancer. The drug reversed tumour traits and reduced tumour growth in mice. Researchers suggest its anti-parasitic action may target cancer via shared metabolic pathways.